• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lung Cancer in Australia.

作者信息

John Thomas, Cooper Wendy A, Wright Gavin, Siva Shankar, Solomon Benjamin, Marshall Henry M, Fong Kwun M

机构信息

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.

出版信息

J Thorac Oncol. 2020 Dec;15(12):1809-1814. doi: 10.1016/j.jtho.2020.09.005.

DOI:10.1016/j.jtho.2020.09.005
PMID:33246594
Abstract
摘要

相似文献

1
Lung Cancer in Australia.澳大利亚的肺癌
J Thorac Oncol. 2020 Dec;15(12):1809-1814. doi: 10.1016/j.jtho.2020.09.005.
2
Lung cancer screening in Australia: progress or procrastination?澳大利亚的肺癌筛查：是进步还是拖延？
Med J Aust. 2016 Jan 18;204(1):4-5. doi: 10.5694/mja15.01109.
3
Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers.对前维特努姆石棉工人间皮瘤、肺癌和石棉沉着病的预测。
Br J Ind Med. 1992 Jun;49(6):451-2. doi: 10.1136/oem.49.6.451-a.
4
Incidence of malignant mesothelioma in New Zealand and Australia: a global snapshot.新西兰和澳大利亚恶性间皮瘤的发病率：全球概况。
N Z Med J. 2015 Dec 18;128(1427):68-71.
5
Helical computed tomography for lung cancer screening.用于肺癌筛查的螺旋计算机断层扫描
Med J Aust. 2003 Aug 4;179(3):125-6. doi: 10.5694/j.1326-5377.2003.tb05467.x.
6
Asbestos exposure and lung cancer.石棉暴露与肺癌。
Pathology. 2004 Dec;36(6):513-4. doi: 10.1080/00313020400012050.
7
Lung cancer screening - practical challenges of confining participation to those who might benefit.肺癌筛查——将参与人群限定为可能受益人群所面临的实际挑战。
Aust N Z J Public Health. 2016 Jun;40(3):205-6. doi: 10.1111/1753-6405.12516. Epub 2016 Mar 30.
8
Lung pathology: the molecular genetics of non-small cell lung cancer.肺部病理学：非小细胞肺癌的分子遗传学
Pathology. 1995 Oct;27(4):295-301. doi: 10.1080/00313029500169173.
9
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.北美、澳大利亚、新西兰及欧洲肺癌组织学亚型的发病率及预后趋势。
Lung Cancer. 2001 Feb-Mar;31(2-3):123-37. doi: 10.1016/s0169-5002(00)00197-5.
10
Crocidolite and mesothelioma.青石棉与间皮瘤
Med J Aust. 1990 Mar 19;152(6):330-1.

引用本文的文献

1
Particulate matter air pollution as a cause of lung cancer: epidemiological and experimental evidence.空气污染中的颗粒物作为肺癌病因：流行病学及实验证据
Br J Cancer. 2025 Jun;132(11):986-996. doi: 10.1038/s41416-025-02999-2. Epub 2025 Apr 4.
2
Quality Indicators for Non-Small Cell Lung Cancer in Queensland, Australia, 2012-2021.2012 - 2021年澳大利亚昆士兰州非小细胞肺癌的质量指标
Thorac Cancer. 2025 Mar;16(5):e70034. doi: 10.1111/1759-7714.70034.
3
Changing trends in lung cancer disease burden between China and Australia from 1990 to 2019 and its predictions.
1990年至2019年中国与澳大利亚肺癌疾病负担的变化趋势及其预测。
Thorac Cancer. 2025 Jan;16(2):e15430. doi: 10.1111/1759-7714.15430. Epub 2024 Dec 12.
4
Patient- and Areal-Level Risk Factors Associated With Lung Cancer Mortality in Victoria, Australia: A Bayesian Spatial Survival Analysis.澳大利亚维多利亚州与肺癌死亡率相关的患者和地区水平风险因素：贝叶斯空间生存分析。
Cancer Med. 2024 Oct;13(19):e70293. doi: 10.1002/cam4.70293.
5
Scoping review of anticancer drug utilization in lung cancer patients at the end of life.终末期肺癌患者抗癌药物使用情况的范围综述
Clin Transl Oncol. 2025 May;27(5):1980-1993. doi: 10.1007/s12094-024-03711-1. Epub 2024 Oct 5.
6
Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology.肺癌的地理差异：关注致癌物、遗传易感性和分子流行病学。
Ther Adv Med Oncol. 2024 Mar 6;16:17588359241231260. doi: 10.1177/17588359241231260. eCollection 2024.
7
Comparison of Lung Cancer Surgery Outcomes in Queensland for Indigenous and Nonindigenous Australians.澳大利亚昆士兰州原住民与非原住民肺癌手术结果的比较。
JTO Clin Res Rep. 2023 Aug 23;4(10):100567. doi: 10.1016/j.jtocrr.2023.100567. eCollection 2023 Oct.
8
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.劳拉替尼：劳拉替尼在澳大利亚晚期ALK重排非小细胞肺癌患者中的真实世界经验。
JTO Clin Res Rep. 2023 Feb 26;4(4):100490. doi: 10.1016/j.jtocrr.2023.100490. eCollection 2023 Apr.
9
Physiotherapy and Exercise Management of People Undergoing Surgery for Lung Cancer: A Survey of Current Practice across Australia and New Zealand.肺癌手术患者的物理治疗与运动管理：澳大利亚和新西兰当前实践调查
J Clin Med. 2023 Mar 9;12(6):2146. doi: 10.3390/jcm12062146.
10
Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya.肯尼亚国家和转诊医院肺癌患者生存结果评估。
Cancer Med. 2023 Apr;12(8):9194-9201. doi: 10.1002/cam4.5658. Epub 2023 Jan 27.